Back to Search

A Phase II Study of Reduced Dose Post Transplantation Cyclophosphamide As GvHD Prophylaxis in Adult Patients with Hematologic Malignancies Receiving HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation


  • Protocol Number: 202309112
  • Principal Investigator: Abboud, Ramzi
  • Cancer Types: Leukemia, Myeloma, and Hematologic

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

Protocol Interventions